תאריך: 19/12/2013 - 21/12/2013
MS MANAGEMENT IN THE ERA OF NEW AND EMERGING IMMUNOMODULATING TREATMENTS
Chairpersons: Mark Freedman, Dimitrios Karussis
הסיקור בחסות
A critical review of the efficacy of the first generation immunomodulating treatments for MS
Dr. Arnon Karni
The Neuroimmunology service, Department of Neurology, TA Souraski Medical canter
New treatment paradigms in multiple sclerosis
Ron Milo MD
Department of Neurology, Barzilai Medical center, Ashkelon; on behalf of the ISNI ad-hoc advisory board
Novel approaches for immunomodulation and neuroprotection in MS
New oral treatments for MS
Professor Mark S.Freedman
Director, Multiple Sclerosis Research Unit
University of Ottawa, Ottawa, Ontario Canada
Case studies on Treatment
Professor Mark S.Freedman
Director, Multiple Sclerosis Research Unit
University of Ottawa, Ottawa, Ontario Canada
